We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Ohio Taxpayers for Lower Drug Prices advocacy group accuses drugmakers of making donations aimed at influencing an election, meeting the definition of a political action committee. Read More
The FDA warned a Chinese drugmaker for inadequate testing and quality control for drug supplies and finished products, as well as numerous other GMP violations. Read More
Insys Pharmaceuticals settled with the state of Illinois for $4.45 million to settle a 2016 lawsuit over the company’s deceptive marketing of opioids, the state attorney general announced. Read More
The FDA is soliciting comments from industry members and shareholders on how direct-to-consumer drug advertising should depict risk information. Read More
A company that warehouses drugs but doesn’t own them fits into a new category to be regulated under a 2013 federal law that aims to tighten security over the drug supply chain by 2023, according to new FDA guidance released Aug. 18. Read More